Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.62 +0.06 (+3.53%)
As of: Oct 2, 2026 · 9:43 AM EDT

Cardiol Therapeutics (CRDL) Return on Assets [ROA] (2021 - 2026)

Updated

Cardiol Therapeutics' Return on Assets [ROA] was -115.43% in Q2 2026, up 60.49 percentage points from -175.91% a year earlier and up 11.50 percentage points from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Cardiol Therapeutics came in at -120.49%, down 13.82 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for three consecutive years, with a four-year change of -58.90 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Assets [ROA] was -106.66% in FY2024 (-49.79 pp), -56.88% in FY2023 (-17.53 pp), -39.35% in FY2022 (+22.24 pp) and -61.59% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q2 2024.
  • Compared with a year earlier, Return on Assets [ROA] was higher in two of the last eight quarters, with an average year-over-year change of -39.42 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 60.49 percentage points); the worst was Q3 2024 (a drop of 106.20 percentage points).
  • Per Business Quant data, CRDL's Return on Assets [ROA] in the three quarters before Q2 2026 was -126.93% (Q1 2026), -182.59% (Q4 2025) and -213.05% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Cardiol Therapeutics 166.43 Mn 166.43 Mn - -115.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -115.43%
Mar 31, 2026 -126.93%
Dec 31, 2025 -182.59%
Sep 30, 2025 -213.05%
Jun 30, 2025 -175.91%
Mar 31, 2025 -139.51%
Dec 31, 2024 -160.11%
Sep 30, 2024 -169.44%
Jun 30, 2024 -105.28%
Mar 31, 2024 -84.54%
Dec 31, 2023 -69.60%
Sep 30, 2023 -63.24%
Jun 30, 2023 -69.57%
Mar 31, 2023 -67.45%
Dec 31, 2022 -62.93%
Sep 30, 2022 -53.43%
Jun 30, 2022 -45.63%
Mar 31, 2022 -38.83%
Dec 31, 2021 -52.93%
Sep 30, 2021 -100.08%
API Access

Cardiol Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY